Annexin A2 as a Novel Diagnostic Marker in Hepatocellular Carcinoma
NCT02541149 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2015-09-04
Summary
This study aimed to investigate the clinical utility of Annexin A2 serum level as a novel diagnostic marker of hepatocellular carcinoma (HCC) and to correlate its level with alpha fetoprotein the current marker ofhepatocellular carcinoma (HCC).
Conditions
- Hepatocellular Carcinoma (HCC)
Interventions
- PROCEDURE
-
blood sample
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-06-30
- Primary Completion
- 2015-06-30
- Completion
- 2015-06-30
More Related Trials
-
Examination the Ability to Early Diagnose HCC by Combining Three Biomarkers Technology Developed by WAKO, And Their Relevance to Cirrhotic of Patients With Various Backgrounds and the Israeli Population.
NCT02826005 ·Status: UNKNOWN ·Phase: NA
-
Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
NCT00373347 ·Status: COMPLETED
-
The Assesment of MMP-1 Genotypes Polymorphism as a Risk Factor for HCC in Chronic HCV Patients With LC
NCT03722628 ·Status: UNKNOWN
-
Plasma MicroRNA for Prediction of Hepatocellular Carcinoma
NCT05449847 ·Status: COMPLETED
-
Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.
NCT01729221 ·Status: UNKNOWN
-
Predictive Power of Share Wave Fibro Scan in HCC After HCV Infection
NCT05105828 ·Status: COMPLETED
-
Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment
NCT01492127 ·Status: UNKNOWN ·Phase: NA
-
Single Center Experience Over a Decade in Living Donor Liver Transplantation for Egyptian Patients With Hepatocellular Carcinoma: Stretching the Limits
NCT01937286 ·Status: COMPLETED
-
TAURINE and HCC PATIENTS
NCT04193761 ·Status: COMPLETED ·Phase: NA
-
Liver Fibrosis and Steatosis in dm Non Invasive Evaluation
NCT05605717 ·Status: UNKNOWN
-
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)
NCT03804593 ·Status: COMPLETED
-
Impact of IL-28B rs12979860 and rs4803217 Gene Polymorphisms Associated With miRNAs Deregulation on HCV-related Hepatocellular Carcinoma
NCT02507882 ·Status: UNKNOWN ·Phase: NA
-
Prevalence of Alpha-1 Antitrypsin Deficiency in Non-Cirrhotic Liver Cancer
NCT07145385 ·Status: NOT_YET_RECRUITING
-
Evaluation of Proteome Multimarker Panel With Multiple Reaction Monitoring as a Surveillance for Hepatocellular Carcinoma
NCT05756699 ·Status: ACTIVE_NOT_RECRUITING
-
A New Prognostic Scoring System for Spontaneous Ruptured Hepatocellular
NCT03504358 ·Status: COMPLETED
-
The Utility of Cell-free Methylation Markers in Blood for Hepatocellular Carcinoma
NCT05576571 ·Status: UNKNOWN
-
The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients
NCT07147335 ·Status: RECRUITING
-
Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver
NCT02288910 ·Status: COMPLETED
-
Case-Control Study of the Glycotest™ HCC Panel Vs AFP for the Detection of Early-stage Hepatocellular Carcinoma
NCT03878550 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of the Role of Aflatoxin as an Environmental Risk Factor Attributable to Liver Cancer in Nile Delta
NCT02461966 ·Status: COMPLETED ·Phase: NA
-
The Clinicopathological and Prognostic Factors of Hepatocellular Carcinoma; 10 Years' Tertiary Center Experience in Egypt
NCT05047146 ·Status: COMPLETED
-
Hepatic Fibrosis Non-invasive Methods Questionnaire
NCT02132351 ·Status: COMPLETED
-
Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study
NCT00629421 ·Status: COMPLETED
-
Searching for the Liver Cancer-Related Biomarkers
NCT00154544 ·Status: UNKNOWN
-
A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers
NCT02272504 ·Status: COMPLETED